Effects of the Nudge Theory-Based Multifaceted Intervention on Reducing Inappropriate Proton Pump Inhibitors Use for Prophylaxis in Hospitalized Patients: A Non-Randomized Controlled Study
- PMID: 40108024
- PMCID: PMC12119425
- DOI: 10.1007/s11606-025-09460-3
Effects of the Nudge Theory-Based Multifaceted Intervention on Reducing Inappropriate Proton Pump Inhibitors Use for Prophylaxis in Hospitalized Patients: A Non-Randomized Controlled Study
Abstract
Background: Inappropriate use of proton pump inhibitors (PPIs) for prophylaxis among hospitalized patients continues to be a significant issue. Previous interventions have often been ineffective and lack evaluation of their longer-term impacts.
Aim: This study aims to assess the clinical and economic effects of a nudge theory-based multifaceted intervention on reducing inappropriate PPI prophylaxis in hospitalized patients.
Methods: This non-randomized controlled study was carried out in a teaching hospital's wards from January 2021 to June 2023, with a 12-month pre-intervention period, a 12-month intervention period (including the first and second stages of intervention), and a post-intervention period with 6-month follow-up. The intervention, based on nudge theory, was implemented among 114 doctors across 10 wards, sequentially involved peer comparison, information provision, and face-to-face feedback. The outcomes were assessed by randomly selecting cases of adult patients who received at least one PPI treatment during hospitalization, and the statistical analysis included univariate analysis, and multivariate and subgroup analyses.
Results: The study included 1782 patients, with a median age of 61 years. During and after intervention, the rate of appropriate PPI use significantly increased by 2.83- to 5.47-fold, rising from 23.82% (147/617) to 46.96% (139/296) after the first stage, to 63.13% (202/320) after the second stage, and remained at 53.01% (291/549) later on. The rate of PPI injections decreased from 92.54 to 74.13-84.12%, the median defined daily doses from 16 to 7-12, and PPI-related expenditures from 484.80 to 156.00-262.99 CNY per-patient. The cost associated with inappropriate PPI use dropped from 161.60 to 0-45.58 CNY per-patient. Subgroup analyses supported these findings.
Conclusion: A nudge theory-based multifaceted intervention led to increased appropriate PPI use, decreased PPI injections, and cost savings, with benefits lasting at least 6 months post-intervention.
Keywords: inappropriateness; longer-lasting effects; multifaceted intervention; nudge theory; prophylaxis; proton pump inhibitors.
© 2025. The Author(s), under exclusive licence to Society of General Internal Medicine.
Conflict of interest statement
Declarations. Conflict of Interest: The authors declare that they do not have a conflict of interest.
Similar articles
-
Deprescribing versus continuation of chronic proton pump inhibitor use in adults.Cochrane Database Syst Rev. 2017 Mar 16;3(3):CD011969. doi: 10.1002/14651858.CD011969.pub2. Cochrane Database Syst Rev. 2017. PMID: 28301676 Free PMC article.
-
Proton pump inhibitors and 1-year risk of adverse outcomes after discharge from internal medicine wards: an observational study in the REPOSI cohort.Intern Emerg Med. 2025 Jun;20(4):1119-1126. doi: 10.1007/s11739-025-03937-z. Epub 2025 Apr 6. Intern Emerg Med. 2025. PMID: 40189643
-
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3. Cochrane Database Syst Rev. 2018. PMID: 29687454 Free PMC article.
-
Safety and efficacy of proton pump inhibitors in preterm infants with gastroesophageal reflux disease.Cochrane Database Syst Rev. 2025 Mar 11;3(3):CD015127. doi: 10.1002/14651858.CD015127.pub2. Cochrane Database Syst Rev. 2025. PMID: 40066936
-
Proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug-induced ulcers and dyspepsia.Cochrane Database Syst Rev. 2025 May 8;5(5):CD014585. doi: 10.1002/14651858.CD014585.pub2. Cochrane Database Syst Rev. 2025. PMID: 40337979
References
-
- Othman F, Card TR, Crooks CJ. Proton pump inhibitor prescribing patterns in the UK: a primary care database study. Pharmacoepidemiol Drug Saf. 2016;25(9):1079-87. - PubMed
-
- Lassalle M, Le Tri T, Bardou M, et al. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study. Eur J Clin Pharmacol. 2020;76(3):449-57. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources